CMKLR1 and neoplasm: Using a transgenic mouse model overexpressing bioactive chemerin under the control of the keratin K5 promoter, we have shown recently that expression of chemerin by keratinocytes inhibits tumor development in the DMBA/TPA model, and this effect is mediated by the main receptor of chemerin, CMKLR1 [23].